Research Archives - Page 32 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Archives - Page 31 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.
Mayo Clinic Laboratory and Pathology Research Roundup: December 12 - Insights
This week's research roundup feature: Most patients with solitary bone plasmacytomas (SBP) progress to multiple myeloma (MM) after definitive radiation therapy as their primary treatment. Whether the presence of high-risk (HR) cytogenetic...
Perspectives Archives - Page 6 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Uptick in Vector-Borne Illnesses in U.S. and What It Means to You - Insights
Illnesses caused by disease-infected ticks, mosquitoes, and fleas have tripled in the U.S. in recent years, according to a new report from the Centers for Disease Control and Prevention. Lyme disease is the most common illness attributed to...
CPT codes and LOINC update: December 2021 - Insights
CPT code updates posted to mayocliniclabs.com during the month of December.
CPT codes and LOINC update: November 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of November.
What's Next in Precision Medicine: Moving New Discoveries into Daily Clinical Care - Insights
Experts in individualized medicine—the concept of shaping health care based on lifestyle, environment, and genetic code—will be in Rochester September 12–13 to present how the newest discoveries can be applied to personalized health care.
Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy individuals with genetic testing and insights with a focus on education.